论文部分内容阅读
目的:分析食道癌患者接受同期放化疗的临床效果。方法:研究对象选取本院2012年7月至2015年6月收治的50例食道癌患者,通过随机数法将其分为研究组与对照组各25例。对照组患者接受单纯化疗方案,研究组患者接受同期放化疗联合治疗,对研究组与对照组患者的缓解率以及治疗安全性进行对比。结果:研究组患者的临床缓解率高于对照组,差异明显(P<0.05);研究组与对照组的不良反应率没有明显的差异,差异无显著性(P>0.05)。结论:食道癌患者接受同期放化疗的临床效果好,安全性高,具有较高的价值。
Objective: To analyze the clinical effect of concurrent chemoradiotherapy in patients with esophageal cancer. Methods: Fifty patients with esophageal cancer who were treated in our hospital from July 2012 to June 2015 were selected and randomly divided into study group and control group (n = 25). Patients in the control group received chemotherapy alone. Patients in the study group received concurrent chemoradiation and chemotherapy, and the response rate and safety of study group and control group were compared. Results: The clinical remission rate in study group was higher than that in control group (P <0.05). There was no significant difference in adverse reaction rate between study group and control group (P> 0.05). Conclusion: The esophageal cancer patients receiving concurrent chemoradiotherapy have good clinical effect, high safety and high value.